See What's Next.
The technologies, research and ideas shaping the future of retinal care.
Can AI Read an Entire 3D OCT Scan?
The next generation of retinal AI is moving beyond single images toward whole volumetric studies.
What's moving now.
Signals worth following across AI, imaging and translational research.
What Can the Retina Reveal About the Rest of the Body?
Oculomics is exploring whether retinal images can reveal clues about vascular, metabolic and neurological health.
02AI for Diabetic Retinopathy: What the Evidence Actually Says
Strong benchmark results are only the beginning. Deployment context changes the answer.
03The Future of Retinal Imaging
Higher resolution, wider fields, richer modalities and more intelligent interpretation are converging.
04Gene Therapy and the Retina: Where the Field Stands
Inherited retinal disease made the eye a proving ground for genetic medicine. The next chapter is broader and harder.
Engineering better vision.
The technologies expanding what we can see and measure in the retina.
Ultra-Widefield Retinal Imaging: Clinical Applications and Limitations
Imaging systems that capture 200 degrees of retina provide documentation and diagnostic information impossible with conventional photography—but artifacts and interpretation challenges persist.
Evidence, explained.
Clear reporting built around evidence, limitations and what comes next.
Gene Therapy and the Retina: Where the Field Stands
Inherited retinal disease made the eye a proving ground for genetic medicine. The next chapter is broader and harder.
What Is Oculomics? Understanding Retinal Biomarkers of Systemic Health
Can retinal imaging reveal information about cardiovascular, metabolic, and neurological health? Research is exploring the possibilities and limitations.
How AI Is Used in Retinal Imaging: Applications, Evidence, and Limitations
A comprehensive overview of artificial intelligence applications in ophthalmology, from FDA-approved screening tools to emerging research.
AI for Diabetic Retinopathy Screening: Decoding the Evidence
Examining what clinical trials and real-world studies actually show about automated DR screening, beyond the benchmark accuracy numbers.
How the retina becomes data.
Deep guides to OCT, OCTA, angiography, artifacts and the technologies changing what can be measured.
What Is OCT? A Modern Guide to Optical Coherence Tomography
How optical coherence tomography turns reflected light into cross-sectional maps of the retina—and why those maps changed retinal care.
OCT vs. OCTA: What’s the Difference?
They share the same optical platform, but one primarily maps retinal structure while the other derives information about motion and blood flow.
OCT Angiography Explained: How OCTA Maps Blood Flow Without Dye
OCTA creates depth-resolved vascular maps from repeated OCT scans. The elegance is real—but so are the assumptions built into the image.
Swept-Source vs. Spectral-Domain OCT: What Actually Changes?
Both can produce excellent retinal scans. The meaningful differences are in acquisition architecture, wavelength, speed, depth and how measurements behave across devices.
Imaging
OCT, OCTA, fundus photography and the technologies changing what clinicians can see.
Explore Imaging →02AI
Artificial intelligence for retinal imaging, screening, diagnosis and decision support.
Explore AI →03Innovation
Emerging devices, therapies and ideas moving retinal care forward.
Explore Innovation →04Research
Important papers decoded: what changed, what the evidence says and what comes next.
Explore Research →05Clinical
Evidence-conscious coverage of advances with potential clinical relevance.
Explore Clinical →06Industry
Companies, platforms, regulation and the business of retinal technology.
Explore Industry →Where science becomes a market.
Regulation, platforms, trials and business-model shifts that could change how retinal care is delivered.
FDA-Cleared AI for Diabetic Retinopathy: How the U.S. Market Evolved
Retinal AI has moved from a regulatory first into a defined device category. The harder questions now are deployment, evidence and what clearance actually means.
Home OCT and Remote Retina Monitoring: From Device to Care Model
Moving OCT beyond the clinic could change how retinal disease is monitored—but the real innovation is the care pathway built around the scan.
The Retina Imaging Stack: Why Workflow Is Becoming Part of the Product
OCT, widefield imaging, AI and data review are converging into connected platforms. That changes how retinal technology companies compete.
The retina as a window.
What can the eye reveal about the rest of the body? Follow the evidence around oculomics, retinal biomarkers and systemic health.
Explore the evidence →Five developments.
Five minutes. Once a week.
A concise evidence-conscious briefing on what changed in retinal science and why it matters.
V1 demo: connect this form to your email provider before launch.